Albion Financial Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $170K | Hold |
7,059
| – | – | 0.01% | 198 |
|
|
2026
Q1 | $198K | Buy |
7,059
+5,817
| +468% | +$155K | 0.01% | 172 |
|
|
2025
Q4 | $30.9K | Sell |
1,242
-400
| -24% | -$10.1K | ﹤0.01% | 301 |
|
|
2025
Q3 | $41.8K | Buy |
1,642
+700
| +74% | +$17.3K | ﹤0.01% | 274 |
|
|
2025
Q2 | $22.8K | Sell |
942
-34
| -3% | -$793 | ﹤0.01% | 300 |
|
|
2025
Q1 | $24.7K | Sell |
976
-1,260
| -56% | -$33K | ﹤0.01% | 293 |
|
|
2024
Q4 | $59.3K | Sell |
2,236
-18
| -0.8% | -$488 | ﹤0.01% | 238 |
|
|
2024
Q3 | $65.2K | Buy |
2,254
+962
| +74% | +$28.1K | ﹤0.01% | 232 |
|
|
2024
Q2 | $36.2K | Sell |
1,292
-220
| -15% | -$6.06K | ﹤0.01% | 258 |
|
|
2024
Q1 | $42K | Sell |
1,512
-31
| -2% | -$860 | ﹤0.01% | 237 |
|
|
2023
Q4 | $44.4K | Buy |
1,543
+31
| +2% | +$937 | ﹤0.01% | 230 |
|
|
2023
Q3 | $50.2K | Sell |
1,512
-11
| -0.7% | -$389 | ﹤0.01% | 213 |
|
|
2023
Q2 | $55.9K | Buy |
1,523
+11
| +0.7% | +$428 | ﹤0.01% | 220 |
|
|
2023
Q1 | $61.7K | Sell |
1,512
-780
| -34% | -$33.7K | 0.01% | 202 |
|
|
2022
Q4 | $117K | Buy |
2,292
+5
| +0.2% | +$240 | 0.01% | 181 |
|
|
2022
Q3 | $100K | Buy |
2,287
+7
| +0.3% | +$340 | 0.01% | 187 |
|
|
2022
Q2 | $120K | Sell |
2,280
-1,594
| -41% | -$81.2K | 0.01% | 190 |
|
|
2022
Q1 | $201K | Sell |
3,874
-223
| -5% | -$11.6K | 0.02% | 197 |
|
|
2021
Q4 | $242K | Buy |
4,097
+46
| +1% | +$2.28K | 0.02% | 199 |
|
|
2021
Q3 | $174K | Sell |
4,051
-104
| -3% | -$4.61K | 0.02% | 192 |
|
|
2021
Q2 | $163K | Buy |
+4,155
| New | +$162K | 0.01% | 195 |
|
|
2020
Q4 | $185K | Sell |
5,030
-1,106
| -18% | -$40.6K | 0.02% | 184 |
|
|
2020
Q3 | $214K | Buy |
+6,136
| New | +$215K | 0.02% | 210 |
|
|
2020
Q1 | – | Sell |
-6,569
| Closed | -$244K | – | 216 |
|
|
2019
Q4 | $244K | Sell |
6,569
-1,575
| -19% | -$56.1K | 0.03% | 185 |
|
|
2019
Q3 | $278K | Sell |
8,144
-15,459
| -65% | -$562K | 0.04% | 170 |
|
|
2019
Q2 | $970K | Sell |
23,603
-591
| -2% | -$23.5K | 0.13% | 108 |
|
|
2019
Q1 | $975K | Sell |
24,194
-73
| -0.3% | -$2.92K | 0.13% | 101 |
|
|
2018
Q4 | $1M | Hold |
24,267
| – | – | 0.16% | 89 |
|
|
2018
Q3 | $1.01M | Sell |
24,267
-949
| -4% | -$36.5K | 0.14% | 96 |
|
|
2018
Q2 | $868K | Hold |
25,216
| – | – | 0.13% | 101 |
|
|
2018
Q1 | $849K | Sell |
25,216
-1,054
| -4% | -$36.2K | 0.13% | 96 |
|
|
2017
Q4 | $903K | Sell |
26,270
-543
| -2% | -$18.5K | 0.14% | 97 |
|
|
2017
Q3 | $908K | Sell |
26,813
-730
| -3% | -$23.5K | 0.14% | 96 |
|
|
2017
Q2 | $878K | Sell |
27,543
-770
| -3% | -$24.3K | 0.15% | 96 |
|
|
2017
Q1 | $919K | Sell |
28,313
-279
| -1% | -$8.8K | 0.14% | 96 |
|
|
2016
Q4 | $881K | Buy |
28,592
+203
| +0.7% | +$6.2K | 0.15% | 94 |
|
|
2016
Q3 | $912K | Buy |
28,389
+321
| +1% | +$10.7K | 0.16% | 94 |
|
|
2016
Q2 | $938K | Sell |
28,068
-116
| -0.4% | -$3.7K | 0.17% | 79 |
|
|
2016
Q1 | $793K | Hold |
28,184
| – | – | 0.13% | 92 |
|
|
2015
Q4 | $863K | Hold |
28,184
| – | – | 0.15% | 82 |
|
|
2015
Q3 | $840K | Sell |
28,184
-157
| -0.6% | -$5.03K | 0.15% | 89 |
|
|
2015
Q2 | $902K | Sell |
28,341
-528
| -2% | -$17.2K | 0.15% | 84 |
|
|
2015
Q1 | $953K | Buy |
28,869
+2,108
| +8% | +$67K | 0.16% | 73 |
|
|
2014
Q4 | $791K | Buy |
26,761
+1,950
| +8% | +$55.9K | 0.14% | 86 |
|
|
2014
Q3 | $696K | Buy |
24,811
+261
| +1% | +$7.33K | 0.12% | 93 |
|
|
2014
Q2 | $691K | Buy |
24,550
+2,920
| +13% | +$83.2K | 0.12% | 98 |
|
|
2014
Q1 | $659K | Buy |
21,630
+1,075
| +5% | +$32.1K | 0.12% | 94 |
|
|
2013
Q4 | $597K | Buy |
20,555
+10,313
| +101% | +$300K | 0.11% | 93 |
|
|
2013
Q3 | $279K | Buy |
10,242
+2,714
| +36% | +$73.8K | 0.06% | 135 |
|
|
2013
Q2 | $200K | Buy |
+7,528
| New | +$208K | 0.04% | 145 |
|
Other funds holding PFE
Albion Financial Group's PFE Position: Q2 2026 in Review
Albion Financial Group held its Pfizer (PFE) position steady in Q2 2026 at 7,059 shares worth $170K. The position accounts for 0.01% of the portfolio, ranked #198.
Albion Financial Group first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.01M in Q3 2018. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Albion Financial Group held 7,059 shares of Pfizer worth $170K as of Q2 2026.
- Albion Financial Group left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.01% of Albion Financial Group's portfolio in Q2 2026, its #198 holding.
- Albion Financial Group first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
- Albion Financial Group's Pfizer position peaked at $1.01M in Q3 2018.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.